The Centers for Medicare & Medicaid Services has taken action against 11 durable-medical-equipment suppliers after identifying more than $3.4 billion in suspected fraudulent billing across 2025 and 2026. The agency says the companies are being barred from future Medicare Advantage Part C and Part D payments through the federal Preclusion List. The case matters beyond the firms involved because inflated or improper claims put pressure on the Medicare dollars that pay for covered care.
What CMS says it found in the supplier cases
In its September 8 release, CMS said the 11 suppliers had more than $3.4 billion in suspected improper billing practices. The suppliers were in the durable medical equipment, prosthetics, orthotics and supplies field, often shortened to DMEPOS. CMS said the group had submitted no claims before 2025, used improper billing practices, and billed for equipment connected to beneficiaries who were already deceased.
The agency also said some equipment was billed for people who did not request or receive it. Those are allegations and program-integrity findings, not a statement that every underlying claim has produced a criminal conviction. That distinction matters: CMS is describing the basis for payment and enrollment action, while other agencies can separately investigate potential civil or criminal violations.
Four of the suppliers had already been revoked from Original Medicare before they began billing Medicare Advantage plans, according to the release. CMS said the resulting action prevents the companies from receiving future payment for items, services or drugs furnished, ordered or prescribed to Medicare beneficiaries and paid by Part C or Part D sponsors.
Free weekday retirement brief: Social Security, Medicare, and the IRS change the rules every year — and no notice arrives in the mail. The Retirement Money Brief by RetireShield explains one change every weekday: what moved, who it affects, and the step to take. Get the free brief.
Why the Preclusion List changes payment eligibility
CMS uses the Preclusion List to identify people and entities that Medicare Advantage and Part D plans generally must not pay. The list is different from a patient-facing directory of approved suppliers. It is a program-integrity tool intended to stop payment after CMS determines that the conduct at issue is detrimental to Medicare’s best interests.
The September action does not mean every person who receives medical equipment has a new task to complete. It does mean beneficiaries should treat unexpected equipment, unfamiliar supplier names and Medicare Summary Notice entries as records worth checking. A claim for braces, catheters or other supplies that does not match actual care is information that can help a plan or Medicare identify a problem sooner.
CMS highlighted examples in the release. One Florida supplier submitted roughly $18.4 million in catheter claims over two days in December 2025, and CMS said its payment-suspension authority stopped the payments. A Texas company submitted about $5.5 million in orthotics claims; CMS said interviews found beneficiaries who did not know the ordering providers, had not heard of the company and did not need the equipment.
What beneficiaries can check without assuming fraud
Medicare claims can be complicated, and a line item alone is not proof that a supplier acted improperly. Equipment can be ordered through clinicians, delivered by a contractor or billed later than the date of service. The practical starting point is a comparison: the item, supplier and service date should make sense against the care actually received.
For Original Medicare, the Medicare Summary Notice is the periodic statement showing claims that Medicare processed. Medicare Advantage members receive an Explanation of Benefits from their plan. When a statement includes an item that was not ordered, was not delivered, or carries a supplier name that cannot be placed, the member can contact the plan or Medicare using the number on the statement and retain the record of the call. A prescriber’s office may also be able to confirm whether an order was written.
This is not merely an administrative issue. CMS said that suspicious billing can drain the Medicare Trust Funds and divert resources from beneficiaries who need care. Claims reporting also helps distinguish a simple billing correction from a pattern that calls for program action.
The consumer-money angle is protecting a shared program
The $3.4 billion figure is the amount of suspected billing CMS identified; it is not a recovery amount or a payment to beneficiaries. The release says that CMS is using data analytics, enrollment authorities, payment safeguards and the Preclusion List to stop questionable payments and limit repeat activity. Those controls operate behind the scenes, but they affect the public funds supporting Medicare coverage.
The agency’s announcement is also a reminder that Medicare fraud prevention is not limited to a single billing system. CMS said the action involved coordination with the Department of Health and Human Services Office of Inspector General. Cases can involve Original Medicare, Medicare Advantage and prescription-drug coverage, so oversight tools need to follow billing behavior across programs rather than assume a prior revocation ends a supplier’s access to payments.
The safest conclusion from the release is narrow: CMS announced current enforcement action against 11 suppliers based on identified suspected billing practices. It does not establish a new benefit, a payment program, or a broad change in what Medicare covers. It shows how existing payment controls are being used in a recent set of cases.
Inside the kit
The first-hour recovery plan, the family code word, the free credit-freeze steps and a fraud evidence and report log.
The Senior Fraud Defense & First-Hour Recovery Kit includes a 9-page kit, the first-hour recovery plan and the family code word.
Open The Senior Fraud Defense & First-Hour Recovery Kit.
AI-assisted research and drafting; reviewed by an editor.
